Is a Cheaper, Off-Label Drug Better for Diabetic Eye Disease?
by DiabetesCare.net | May 21, 2015 | Medicine Cabinet
Genentech is a biotech company based in South San Francisco, Ca., and is a member of the Roche Group. The company has the distinction of having two medicines being used for the treatment of diabetic retinopathy. One of these drugs, Lucentis (ranibizumab), was approved back in February to be used in the treatment of diabetes retinopathy for patients with...
GLP-1 Agonist Use in Type 1 Diabetes
by DiabetesCare.net | May 8, 2015 | Medicine Cabinet
For those who have type 1 diabetes as well as those who help treat it, it goes without saying that managing type 1 diabetes is very complex and can be frustrating. However, every enterprising type 1 that I work with will look at every treatment angle possible to help reduce blood glucose, hypoglycemia, and weight gain. The term “off-label” does not scare...
Preventing the Onset of Type 2 Diabetes
by DiabetesCare.net | May 1, 2015 | Practice Management
The U.S. diabetes statistics are well known: 29.1 million people, or 9.3% of the American population has diabetes and 8.1 million are undiagnosed. The statistics for prediabetes are perhaps less well known but more significant for the future of American health and healthcare. 86 million Americans, or 1 in 3, have prediabetes but nearly 90 percent of these...
